Ryan D Kaya

Dr. Ryan D Kaya


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in Neurorehabilitation and Neural Repair
Verified
Journal Article
Closed access
JAJay L. Alberts
Jay L. Alberts
RKRyan D Kaya
Ryan D Kaya
APAmanda L. Penko
Amanda L. Penko
MSMatthew Streicher
Matthew Streicher
EZEric M. Zimmerman
Eric M. Zimmerman
ARAnson B. Rosenfeldt
Anson B. Rosenfeldt
Background: Postural instability and gait dysfunction (PIGD) is a cardinal symptom of Parkinson’s disease (PD) and is exacerbated under dual-task conditions. Dual-task training (DTT), enhances gait performance, however it is time and cost intensive. Digitizing DTT via the Dual-task Augmented Reality Treatment (DART) platform can expand the availability of an effective intervention to address PIGD. Objective: The aim of this project was to evaluate DART in the treatment of PIGD in people with PD compared to a Traditional DTT intervention. It was hypothesized that both groups would exhibit significant improvements in gait, and the improvements for the DART group would be non-inferior to Traditional DTT. Methods: A single-blind randomized controlled trial was conducted with 47 PD participants with PIGD. Both groups completed 16 therapeutic sessions over 8 weeks; the DART platform delivered DTT via the Microsoft HoloLens2. Primary outcomes included clinical ratings and single- and dual-task gait biomechanical outcomes. Results: Clinical measures of PD symptoms remained stable for DART and Traditional DTT groups. However, both groups exhibited a significant increase in gait velocity, cadence, and step length during single- and multiple dual-task conditions following the interventions. Improvements in gait velocity in the DART group were non-inferior to Traditional DTT under the majority of conditions. Conclusion: Non-inferior improvements in gait parameters across groups provides evidence of the DART platform being an effective digital therapeutic capable of improving PIGD. Effective digital delivery of DTT has the potential to increase use and accessibility to a promising, yet underutilized and difficult to administer, intervention for PIGD. Clinical Trial Registration: ClinicalTrials.gov Dual-task Augmented Reality Treatment for Parkinson’s Disease (DART) NCT04634331; posted November 18, 2020.

12 November 2022 in Sensors
Verified
Journal Article
Open access
PDF file
JAJay Lance Alberts
Jay Lance Alberts
RKRyan D Kaya
Ryan D Kaya
KSKathryn Scelina
Kathryn Scelina
LSLogan Scelina
Logan Scelina
EZEric Zimmerman
Eric Zimmerman
ARAnson Rosenfeldt
Anson Rosenfeldt
Augmented reality (AR) may be a useful tool for the delivery of dual-task training. This manuscript details the development of the Dual-task Augmented Reality Treatment (DART) platform for individuals with Parkinson’s disease (PD) and reports initial feasibility, usability, and efficacy of the DART platform in provoking dual-task interference in individuals with PD. The DART platform utilizes the head-mounted Microsoft HoloLens2 AR device to deliver concurrent motor and cognitive tasks. Biomechanical metrics of gait and cognitive responses are automatically computed and provided to the supervising clinician. To assess feasibility, individuals with PD (N = 48) completed a bout of single-task and dual-task walking using the DART platform. Usability was assessed by the System Usability Scale (SUS). Dual-task interference was assessed by comparing single-task walking and walking during an obstacle course while performing a cognitive task. Average gait velocity decreased from 1.06 to 0.82 m/s from single- to dual-task conditions. Mean SUS scores were 81.3 (11.3), which placed the DART in the “good” to “excellent” category. To our knowledge, the DART platform is the first to use a head-mounted AR system to deliver a dual-task paradigm and simultaneously provide biomechanical data that characterize cognitive and motor performance. Individuals with PD were able to successfully use the DART platform with satisfaction, and dual-task interference was provoked. The DART platform should be investigated as a platform to treat dual-task declines associated with PD.

11 February 2025 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
SASaar Anis
Saar Anis
EZEric Zimmerman
Eric Zimmerman
AJA. Elizabeth Jansen
A. Elizabeth Jansen
RKRyan D Kaya
Ryan D Kaya
HFHubert H. Fernandez
Hubert H. Fernandez
JAJay Lance Alberts
Jay Lance Alberts
Accurate prediction of falls in patients with Parkinson's disease (PWP) is crucial for effective prevention efforts. Historically, fall risk models have heavily relied on motor features, overlooking the vital cognitive-motor interplay essential for locomotion. Baseline assessments and year-long fall data from the CYClical Lower Extremity Exercise for Parkinson's disease II (CYCLE-II) trial's control group were utilized. A LASSO logistic regression model assessed thirty-seven demographic, motor, and cognitive variables to identify key fall predictors. To explore the practical implementation of predicting falls in a clinical setting, a second model was developed using a subset of nine candidate measures conducive for retrieval from electronic medical records. Models' accuracy was validated against Paul et al.'s 3-step fall prediction model. Analysis included 123 participants (mean age 65.3 ± 8.3 years, 66 % males, mean disease duration 4.9 ± 4.1 years). Seventy-two participants (58.5 %) fell at least once; with 33.1 % occurring during walking, 34.4 % resulting in injuries. The initial model identified 8 predictors with an AUC of 0.68. The second model, incorporating disease duration and cognitive tests, achieved an AUC of 0.67, comparable to Paul et al.'s validation (AUC 0.66). Participants with poorer information processing and spatial memory were more prone to falling over the 12-month period. Impaired cognitive performance and longer disease duration were powerful predictors in identifying a future fall in PWP. The link between cognitive performance and potential for falling reinforces the strong interplay between gait and cognition.

29 April 2025 in Clinical Parkinsonism & Related Disorders
Verified
Journal Article
Open access
BBBrendan Baugher
Brendan Baugher
RKRyan D Kaya
Ryan D Kaya
CSClaire Sonneborn
Claire Sonneborn
KBKenneth B. Baker
Kenneth B. Baker
HFHubert H. Fernandez
Hubert H. Fernandez
JLJames Liao
James Liao
Freezing of gait (FoG) is a treatment-resistant symptom of Parkinson disease (PD). Augmented reality (AR) cues have been investigated as a therapy for FoG, with inconclusive results from a limited array of AR constructs. Compare four modalities of a novel AR cue to physical and no-cue controls. Presence of FoG in PD was required; exclusion criteria included dementia, severe vision loss, and significant gait-disrupting comorbidities. Participants completed six walking tasks, featuring different cueing conditions in a crossover fashion, in a holographic hallway displayed by an AR headset. A conventional physical cue was presented first, followed by other conditions in randomized order (hand-controlled AR cue, observer-controlled AR cue, eye-controlled AR cue, constant AR cue, no-cue control). Primary outcomes were FoG duration and incidence, manually annotated. Secondary outcomes included survey questions and gait parameters derived from IMUs. Thirty-six participants completed testing. The observer-controlled AR cue produced lower FoG duration than the no-cue, physical, and hand-controlled AR cue conditions (N = 36, p ≤ 0.006, Wilcoxon effect size (WES) ≥ 0.46). The constant cue reduced FoG incidence compared to all other conditions (N = 36, p ≤ 0.016, WES ≥ 0.40). Participants' preferred AR cues decreased FoG duration (N = 28, p ≤ 0.004, WES ≥ 0.48) and incidence (N = 28, p ≤ 0.022, WES ≥ 0.38) compared to controls. Differences in kinematic outcomes were negligible. Survey results indicated receptiveness toward AR cueing, with diversity in preferred cue activation modalities. No significant adverse events occurred. AR cueing decreased FoG incidence and duration compared to controls. Efficacy of discrete cueing modalities likely depends on user intrinsic factors, such as preference.

Verified
Journal Article
Open access
PDF file
ABAndrew Bazyk
Andrew Bazyk
RKRyan D Kaya
Ryan D Kaya
CWColin Waltz
Colin Waltz
EZEric Zimmerman
Eric Zimmerman
JJJoshua D. Johnston
Joshua D. Johnston
JAJay Lance Alberts
Jay Lance Alberts
Background/Objectives: Technological approaches for the objective, quantitative assessment of motor functions have the potential to improve the medical management of people with Parkinson’s disease (PwPD), offering more precise, data-driven insights to enhance diagnosis, monitoring, and treatment. Markerless motion capture (MMC) is a promising approach for the integration of biomechanical analysis into clinical practice. The aims of this project were to evaluate a commercially available MMC system, develop and validate a custom MMC data processing algorithm, and evaluate the effectiveness of the algorithm in discriminating fine motor performance between PwPD and healthy controls (HCs). Methods: A total of 58 PwPD and 25 HCs completed finger-tapping assessments, administered and recorded by a self-worn augmented reality headset. Fine motor performance was evaluated using the headset’s built-in hand tracking software (Native-MMC) and a custom algorithm (CART-MMC). Outcomes from each were compared against a gold-standard motion capture system (Traditional-MC) to determine the equivalence. Known-group validity was evaluated using CART-MMC. Results: A total of 82 trials were analyzed for equivalence against the Traditional-MC, and 152 trials were analyzed for known-group validity. The CART-MMC outcomes were statistically equivalent to Traditional-MC (within 5%) for tap count, frequency, amplitude, and opening velocity metrics. The Native-MMC did not meet equivalence with the Traditional-MC, deviating by an average of 24% across all outcomes. The CART-MMC captured significant differences between PwPD and HCs for tapping amplitude, amplitude variability, frequency variability, finger opening and closing velocities, and their respective variabilities, and normalized path length. Conclusions: The biomechanical data gathered using a commercially available augmented reality device and analyzed via a custom algorithm accurately characterize fine motor performance in PwPD.

12 June 2025 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
ARAnson Rosenfeldt
Anson Rosenfeldt
SDSara Davidson
Sara Davidson
RKRyan D Kaya
Ryan D Kaya
EWElizabeth West
Elizabeth West
JLJames Liao
James Liao
JAJay Lance Alberts
Jay Lance Alberts
People with Parkinson's disease (PwPD) who have undergone deep brain stimulation (DBS) surgery have been historically excluded from rehabilitation clinical trials. This project investigated the safety, feasibility, and preliminary efficacy of a dual-task training intervention aimed at improving postural instability and gait dysfunction (PIGD) in PwPD with DBS. Symptoms of PIGD were measured with the 2-Minute Walk Test (2MWT) and Timed Up and Go (TUG) test under single- and dual-task conditions. Five participants completed 97.5 % of the 16 intervention sessions without serious adverse events. One participant was excluded from the motor analysis due to frequent changes in DBS settings. Of the four participants included in the analysis, all demonstrated improvement in the TUG under single- and dual-task conditions. During the 2MWT, two participants experienced an improvement in gait speed under single-task conditions, and three experienced an improvement under dual-task conditions. Initial data suggest dual-task training is safe and feasible for PwPD with DBS. Having DBS presents unique challenges including advanced motor symptoms, autonomic dysfunction, and potential changes in DBS parameters, that impact intervention delivery, adherence, and outcomes. Despite unique challenges, appropriately selected PwPD with DBS have the capacity to improve PIGD symptoms with dual-task training. To facilitate generalizability across the PD continuum, future rehabilitation trials including PwPD with DBS are justified and recommended.